X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

IN VIVO

期刊標題檢索 IN VIVO 最新評論: fanqiangcaixing (2023-09-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[IN VIVO]您好,您是該頁面的第 33770 位訪客。

期刊簡介
期刊名稱IN VIVO IN VIVO
LetPub Score
5.2
50 ratings
Rate

Reputation
6.3

Influence
3.9

Speed
7.0

期刊簡稱IN VIVO
ISSN0258-851X
E-ISSN1791-7549
h-index54
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.200.5550.679
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: General Biochemistry, Genetics and Molecular Biology
Q291 / 221
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Pharmacology
Q3169 / 313
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q3147 / 230

自引率 (2023-2024)5.60%自引率趨勢
掲載範囲
IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management.

The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
官方網站http://iv.iiarjournals.org/
在線稿件提交http://iv.iiarjournals.org/site/misc/submissions.xhtml
開放訪問No
出版商International Institute of Anticancer Research
主題領域医学
出版國/地區GREECE
發行頻率隔月刊行
創刊年0
每年文章數356每年文章數趨勢
黃金OA百分比99.75%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3130/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0258-851X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【IN VIVO】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    JOURNAL OF CLINICAL INVESTIGATIONH-index: 447

    CiteScore: 24.50
    EMBO Molecular MedicineH-index: 90

    CiteScore: 17.70
    JOURNAL OF BIOMEDICAL SCIENCEH-index: 71

    CiteScore: 18.50
    CLINICAL SCIENCEH-index: 126

    CiteScore: 11.40
    Journal of Translational MedicineH-index: 87

    CiteScore: 10.00
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINEH-index: 80

    CiteScore: 12.30
    JOURNAL OF MOLECULAR MEDICINE-JMMH-index: 127

    CiteScore: 9.30
    ARCHIVES OF MEDICAL RESEARCHH-index: 72

    CiteScore: 12.50
    Orphanet Journal of Rare DiseasesH-index: 87

    CiteScore: 6.30
    XENOTRANSPLANTATIONH-index: 56

    CiteScore: 6.80
    學科內最受檢索的期刊 頁面查看次數
    Journal of Translational Medicine255705
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE172392
    JOURNAL OF CLINICAL INVESTIGATION168250
    JOURNAL OF BIOMEDICAL SCIENCE131244
    CLINICAL SCIENCE88157
    MEDICAL SCIENCE MONITOR84728
    Advances in Experimental Medicine and Biology81138
    EMBO Molecular Medicine79440
    EXPERIMENTAL BIOLOGY AND MEDICINE75992
    JOURNAL OF MOLECULAR MEDICINE-JMM75282
  •  

    IN VIVO IN VIVO
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [IN VIVO] 的評論撰寫評論
作者: Nick Aly


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-25 14:38:17 評論於
fanqiangcaixing
(0) 讚! | Nick Aly

作者: 是你的俊宇呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-23 17:54:35 評論於
How can we solve this? I'm also puzzled
(2) 讚! | 是你的俊宇呀

作者: 是你的俊宇呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-22 15:49:37 評論於
Can I ask who the witness is when registering? How should we handle this?
(0) 讚! | 是你的俊宇呀

作者: 长安广运


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-17 11:08:37 評論於
How do we solve this problem?
(0) 讚! | 长安广运

作者: 运莱来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-29 23:08:45 評論於
So the question remains, what should we do next?
(0) 讚! | 运莱来了

作者: Hardy Wheeler


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-06 14:52:26 評論於
I would like to have this paragraph translated into English and Japanese.
Thank you!
(0) 讚! | Hardy Wheeler

作者: 努力啊大雅珍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-30 09:10:16 評論於
How did you solve it at that time?
(0) 讚! | 努力啊大雅珍

作者: 花拳阳霁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-31 11:35:18 評論於
Whenever I try to register, it keeps prompting "Prove you are human*. Do you have this situation as well? How did you solve it? Thank you
(0) 讚! | 花拳阳霁

作者: 娜娜酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-18 17:06:36 評論於
A meta, rejected in 10 days with no comments (maybe the only advantage is that it was fast, so I can submit it to another journal quickly ?
(0) 讚! | 娜娜酱吖

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:51:38 評論於
Highlight the innovation of your own research, showing distinctive characteristics different from others. The magnitude of the difference is another issue; the important thing is to have a distinction. As long as there is a distinction, it is considered innovation
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:11:20 評論於
Given the diversity and complexity of biology, it is perfectly acceptable for different results to emerge and be published, as scientific research itself allows and encourages questioning, supplementing, and improving upon previous knowledge, even overturning it. When writing a paper, it is important to focus on two main strategies: accurately presenting materials and methods as well as results, especially where they differ from others, and emphasizing these differences in detail; in the discussion section, do not avoid contradictions, compare similarities and differences with previous research, and attempt to provide reasonable and effective explanations
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 17:21:26 評論於
How to handle it when my discussion conflicts with a previously published article?
(0) 讚! | 八坂篷蔚

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 15:36:53 評論於
How to highlight the innovation of an article during discussion?
(0) 讚! | Oswald Edie

作者: 无冬轩秀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-29 19:55:33 評論於
Did you submit this magazine?
(0) 讚! | 无冬轩秀

作者: Oliver Jerry


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-10-25 23:50:09 評論於
Can you please be more specific?
(0) 讚! | Oliver Jerry

作者: 稻妻若兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-19 09:19:35 評論於
I still suggest my friends in China not to subscribe to this magazine. I looked through all the articles online from the 2018 issues, and none of them were from mainland China. There were quite a few articles from Taiwan, so it is clear that the editorial department has a bias against content from mainland China
(0) 讚! | 稻妻若兰

作者: 北海宇航


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-06 09:03:09 評論於
Subscribing to this magazine is just a waste of time. They won't give feedback even after half a month. It's better to submit to another magazine instead. This is just a personal suggestion, for reference only
(0) 讚! | 北海宇航

作者: 南川若星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-23 18:20:34 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Experience sharing: Although the score is not high, it is also not easy to be accepted. The submission was rejected in 10 days without any review comments
(0) 讚! | 南川若星

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 22:12:46 評論於
In any case, the situation with this bear won't change, so as long as it doesn't fall, we should consider ourselves lucky
(0) 讚! | 凌霄高洁

作者: 神古苑博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-16 10:50:27 評論於
@FullFootballClub On the top of this page, there is the magazine homepage and the submission link. Just click to enter
(0) 讚! | 神古苑博

作者: 碧桃寻梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-15 20:04:25 評論於
Where can I find the submission link for this magazine?
(0) 讚! | 碧桃寻梅

作者: 暗月寺吉月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-01 18:13:43 評論於
Review Speed: 1.0 Experience sharing: The review was relatively fast! I received a response within two weeks! (Rejection straight away) Blunt and rude! The reasons were very simple! A couple of sentences that were dismissive, without any constructive feedback! If you are in a hurry, maybe you can try your luck online!
(0) 讚! | 暗月寺吉月

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-01-08 17:34:32 評論於
I once submitted an article, but received a rejection letter from the editor with no feedback. However, the feedback came back in just 3 weeks
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [IN VIVO] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*